Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Human cells in plasma-derived gels can potentially mimic hair follicle environments, improving hair regeneration therapies.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Two growth factors, PDGF and FGF2, can potentially be used together to grow enough cells for a hair loss treatment, but their exact function on human cells needs further confirmation.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

CGF-PF may improve hair loss treatment by targeting hair follicle stem cells more effectively.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

Blocking EGFR in mice causes hair loss and skin changes.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

EGF and KGF affect wool fineness in Gansu alpine Merino sheep.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Multi-peptide factors from fibroblasts may stimulate hair growth by increasing growth factors and β-catenin in hair cells.

The method identified and measured ten compounds from Eclipta prostrata, showing significant enzyme inhibitory effects.

Glucosylceramides are essential for healthy skin and proper wound healing.

Dermoscopy helped diagnose a rare skin disease which slightly improved with treatment.

Compound 6 is a promising candidate for better wound healing.

EGFR inhibitors can cause skin eruptions different from acne, needing specific management.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

PRP preparation partially activates platelets, causing varied growth factor release.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

Freeze-dried platelet-rich plasma boosts bone growth in gum treatment.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.